NASDAQ:PODD
Insulet Corporation
- Stock
locale
United States
market
STOCKSindustry
Medical - Deviceswebsite
www.insulet.comipo date
May 15, 2007
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approxima...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus